Patents by Inventor Julia M. Amadio

Julia M. Amadio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200352961
    Abstract: According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided. In various embodiments, such formulations are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
    Type: Application
    Filed: April 1, 2020
    Publication date: November 12, 2020
    Applicant: TherapeuticsMD, Inc.
    Inventors: Brian A. BERNICK, Julia M. AMADIO, Peter H.R. PERSICANER, Thorsteinn THORSTEINSSON, Janice Louise CACACE, Frederick D. SANCILIO, Neda IRANI
  • Publication number: 20200338091
    Abstract: Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).
    Type: Application
    Filed: June 12, 2018
    Publication date: October 29, 2020
    Inventors: Brian A. Bernick, Julia M. Amadio, Sebastian Mirkin
  • Patent number: 10806740
    Abstract: Pharmaceutical formulations for co-administering estradiol and progesterone are provided herein. In some embodiments, the formulation comprises solubilized estradiol, suspended progesterone, and a medium chain (C6-C12) oil.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: October 20, 2020
    Assignee: TherapeuticsMD, Inc.
    Inventors: Peter H. R. Persicaner, Brian A. Bernick, Julia M. Amadio
  • Patent number: 10806697
    Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: October 20, 2020
    Assignee: TherapeuticsMD, Inc.
    Inventors: Brian A. Bernick, Julia M. Amadio, Peter H. R. Persicaner
  • Publication number: 20200323881
    Abstract: According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided. In various embodiments, such formulations are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
    Type: Application
    Filed: June 25, 2020
    Publication date: October 15, 2020
    Inventors: Brian A. Bernick, Julia M. Amadio, Peter H.R. Persicaner, Thorsteinn Thorsteinsson, Janice Louise Cacace, Frederick D. Sancilio, Neda Irani
  • Publication number: 20200289529
    Abstract: According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided.
    Type: Application
    Filed: March 27, 2020
    Publication date: September 17, 2020
    Applicant: TherapeuticsMD, Inc.
    Inventors: Brian A. BERNICK, Julia M. AMADIO, Peter H.R. PERSICANER, Thorsteinn THORSTEINSSON, Janice Louise CACACE, Frederick D. SANCILIO, Neda IRANI
  • Publication number: 20200281938
    Abstract: Pharmaceutical compositions for co-administering estradiol and progesterone to a human subject in need thereof are provided. In some embodiments, the pharmaceutical composition comprises solubilized estradiol, suspended progesterone, and a solubilizing agent comprising a medium chain (C6-C12) oil.
    Type: Application
    Filed: May 27, 2020
    Publication date: September 10, 2020
    Inventors: Brian A. BERNICK, Peter H.R. PERSICANER, Julia M. Amadio
  • Publication number: 20200281941
    Abstract: Estrogen and progesterone replacement therapies are provided herein. Among others, the following formulations are provided herein: solubilized estradiol without progesterone; micronized progesterone without estradiol; micronized progesterone with partially solubilized progesterone; solubilized estradiol with micronized progesterone; solubilized estradiol with micronized progesterone in combination with partially solubilized progesterone; and solubilized estradiol with solubilized progesterone.
    Type: Application
    Filed: May 27, 2020
    Publication date: September 10, 2020
    Inventors: Brian A. Bernick, Janice Louise Cacace, Peter H.R. Persicaner, Neda Irani, Julia M. Amadio
  • Publication number: 20200281940
    Abstract: Estrogen and progesterone replacement therapies are provided herein. Among others, the following formulations are provided herein: solubilized estradiol without progesterone; micronized progesterone without estradiol; micronized progesterone with partially solubilized progesterone; solubilized estradiol with micronized progesterone; solubilized estradiol with micronized progesterone in combination with partially solubilized progesterone; and solubilized estradiol with solubilized progesterone.
    Type: Application
    Filed: May 27, 2020
    Publication date: September 10, 2020
    Inventors: Brian A. BERNICK, Janice Louise CACACE, Peter H.R. PERSICANER, Neda IRANI, Julia M. AMADIO
  • Publication number: 20200276210
    Abstract: According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided.
    Type: Application
    Filed: May 15, 2020
    Publication date: September 3, 2020
    Applicant: TherapeuticsMD, Inc.
    Inventors: Brian A. BERNICK, Julia M. AMADIO, Peter H.R. PERSICANER, Thorsteinn THORSTEINSSON, Janice Louise CACACE, Frederick D. SANCILIO, Neda IRANI
  • Publication number: 20200230050
    Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
    Type: Application
    Filed: March 30, 2020
    Publication date: July 23, 2020
    Applicant: TherapeuticsMD, Inc.
    Inventors: Brian A. BERNICK, Julia M. AMADIO, Peter H.R. PERSICANER
  • Publication number: 20200230153
    Abstract: According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided. In various embodiments, such formulations are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
    Type: Application
    Filed: April 1, 2020
    Publication date: July 23, 2020
    Applicant: TherapeuticsMD, Inc.
    Inventors: Brian A. BERNICK, Julia M. AMADIO, Peter H.R. PERSICANER, Thorsteinn THORSTEINSSON, Janice Louise CACACE, Frederick D. SANCILIO, Neda IRANI
  • Publication number: 20200230154
    Abstract: According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided. In various embodiments, such formulations are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
    Type: Application
    Filed: April 1, 2020
    Publication date: July 23, 2020
    Applicant: TherapeuticsMD, Inc.
    Inventors: Brian A. BERNICK, Julia M. AMADIO, Peter H.R. PERSICANER, Thorsteinn THORSTEINSSON, Janice Louise CACACE, Frederick D. SANCILIO, Neda IRANI
  • Publication number: 20200206242
    Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
    Type: Application
    Filed: October 22, 2014
    Publication date: July 2, 2020
    Inventors: Brian A. Bernick, Julia M. Amadio
  • Patent number: 10675288
    Abstract: Estrogen and progesterone replacement therapies are provided herein. Among others, the following formulations are provided herein: solubilized estradiol without progesterone; micronized progesterone without estradiol; micronized progesterone with partially solubilized progesterone; solubilized estradiol with micronized progesterone; solubilized estradiol with micronized progesterone in combination with partially solubilized progesterone; and solubilized estradiol with solubilized progesterone.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: June 9, 2020
    Assignee: TherapeuticsMD, Inc.
    Inventors: Brian A. Bernick, Janice Louise Cacace, Peter H. R. Persicaner, Neda Irani, Julia M. Amadio
  • Publication number: 20200171050
    Abstract: According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided. In various embodiments, such formulations are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
    Type: Application
    Filed: January 27, 2020
    Publication date: June 4, 2020
    Inventors: Brian A. Bernick, Julia M. Amadio, Peter H.R. Persicaner, Thorsteinn Thorsteinsson, Janice Louise Cacace, Frederick D. Sancilio, Neda Irani
  • Patent number: 10668082
    Abstract: Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: June 2, 2020
    Assignee: TherapeuticsMD, Inc.
    Inventors: Sebastian Mirkin, Julia M. Amadio, Brian A. Bernick
  • Publication number: 20200155465
    Abstract: Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).
    Type: Application
    Filed: May 9, 2018
    Publication date: May 21, 2020
    Inventors: Sebastian Mirkin, Julia M. Amadio, Brian A. Bernick
  • Patent number: 10639375
    Abstract: Various pharmaceutical formulations are disclosed herein. For example, a pharmaceutical formulation is disclosed comprising ultra-micronized progesterone.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: May 5, 2020
    Assignee: TherapeuticsMD, Inc.
    Inventors: Brian A. Bernick, Julia M. Amadio, Peter H. R. Persicaner, Janice Louise Cacace, Thorsteinn Thorsteinsson, Frederick D. Sancilio, Neda Irani
  • Patent number: RE48019
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: June 2, 2020
    Assignee: TherapeuticsMD, Inc.
    Inventors: Frederick D. Sancilio, Thorsteinn Thorsteinsson, Julia M. Amadio